Federal Data Hub › HRSA 340B · JSON

PAWHUSKA HOSPITAL INC.

340B ID CAH371309-00

ParticipatingCritical Access Hospital

PAWHUSKA HOSPITAL INC. is a Critical Access Hospital enrolled in the federal 340B Drug Pricing Program in PAWHUSKA, OK. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 22 contract-pharmacy arrangement(s) (1 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (22)

PharmacyLocationBeginTerminatedPharmacy ID
CYSTIC FIBROSIS SERVICES, LLCFRISCO, TX2018-10-012019-10-01110069
CYSTIC FIBROSIS SERVICES, LLCFRISCO, TX2020-10-012026-04-23110069
PRIME THERAPEUTICS SPECIALTY PHARMACY LLORLANDO, FL2018-10-012019-10-0139182
PRIME THERAPEUTICS SPECIALTY PHARMACY LLORLANDO, FL2020-10-012022-10-0139182
WALGREEN CO.BARTLESVILLE, OK2018-10-012019-10-013855
WALGREEN CO.BARTLESVILLE, OK2020-10-012026-04-233855
WALGREEN CO.BARTLESVILLE, OK2018-10-012019-10-01109897
WALGREEN CO.BARTLESVILLE, OK2020-10-012026-04-23109897
WALGREEN CO.OKLAHOMA CITY, OK2018-10-012019-10-01110878
WALGREEN CO.OKLAHOMA CITY, OK2020-10-012026-04-23110878
WALGREEN CO.TULSA, OK2018-10-012019-10-01115731
WALGREEN CO.TULSA, OK2020-10-012026-04-23115731
WALGREENS SPECIALTY PHARMACY, LLCCANTON, MI2018-10-012019-10-014981
WALGREENS SPECIALTY PHARMACY, LLCCANTON, MI2020-10-012026-04-234981
WALGREENS SPECIALTY PHARMACY, LLCBEAVERTON, OR2018-10-012019-10-014982
WALGREENS SPECIALTY PHARMACY, LLCBEAVERTON, OR2020-10-012022-10-014982
WALGREENS SPECIALTY PHARMACY, LLCPITTSBURGH, PA2018-10-012019-10-014953
WALGREENS SPECIALTY PHARMACY, LLCPITTSBURGH, PA2020-10-012026-04-234953
WALGREENS SPECIALTY PHARMACY, LLCFRISCO, TX2018-10-012019-10-014980
WALGREENS SPECIALTY PHARMACY, LLCFRISCO, TX2020-10-012026-04-234980
WEIGANTS' PHARMACYPAWHUSKA, OK2022-07-01—132621
Walgreens #21373Northlake, TX2022-01-012026-04-23131939

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.